Why Lam Research (LRCX) Is Up After Unveiling a Major R&D Expansion in Oregon

Lam Research Corporation

Lam Research Corporation

LRCX

0.00

  • Lam Research celebrated the opening of its new US$65 million, 120,000-square-foot office building in Tualatin, Oregon, which adds capacity for up to 700 employees and expands the company's research and development operations in the Silicon Forest.
  • This expansion highlights Lam's multi-year commitment to enhancing facilities in key locations, supporting its role as a supplier to the rapidly evolving semiconductor industry amid AI-driven demand.
  • We'll explore how Lam's significant new investment in Oregon advances its long-term growth story in semiconductor equipment for the AI era.

Find companies with promising cash flow potential yet trading below their fair value.

Lam Research Investment Narrative Recap

To be a Lam Research shareholder, you need to believe in the long-term theme of advancing semiconductor technology, particularly for AI, driving ongoing demand for wafer fabrication equipment and innovation. While the new Tualatin office investment strengthens Lam's research capacities and supports future growth catalysts, it does not materially change the biggest short-term risk: uncertain demand from China and possible impacts from evolving tariffs and export restrictions.

One recent highlight tied closely to Lam's growth catalysts is the launch of the VECTOR TEOS 3D deposition tool, targeting advanced chip packaging challenges. This product innovation complements the company’s R&D footprint expansion in Tualatin, reinforcing Lam’s position at the cutting edge of solutions for AI-driven semiconductor manufacturing and supporting near-term order momentum.

But despite these advancements, investors should be aware that shifting geopolitical risks in China could still ...

Lam Research's outlook anticipates $23.6 billion in revenue and $6.7 billion in earnings by 2028. This scenario is based on an annual revenue growth rate of 8.5% and an increase in earnings of $1.3 billion from the current level of $5.4 billion.

Uncover how Lam Research's forecasts yield a $158.52 fair value, in line with its current price.

Exploring Other Perspectives

LRCX Community Fair Values as at Nov 2025
LRCX Community Fair Values as at Nov 2025

Sixteen Community members on Simply Wall St see Lam Research’s fair value anywhere from US$64.26 to US$158.52 per share. These differences matter, especially with export risks to China potentially shaping Lam’s future growth and investor confidence.

Explore 16 other fair value estimates on Lam Research - why the stock might be worth less than half the current price!

Build Your Own Lam Research Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

  • A great starting point for your Lam Research research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision.
  • Our free Lam Research research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Lam Research's overall financial health at a glance.

Looking For Alternative Opportunities?

These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

  • The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 25 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
  • AI is about to change healthcare. These 30 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
  • This technology could replace computers: discover 28 stocks that are working to make quantum computing a reality.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.